NRX PHARMA (NRXP)
$1.85
0.02 (1.32%)
NRXP Stock: This Covid-19 Treatment Could Prime NRx Pharmaceuticals for Big Gains
NRXP stock came to investors' attention last year with its Covid-19 treatment. Now, it's looking like a great play as it eyes up EUA.

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:

Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$2.01
Market Cap
34.00M
PE Ratio
-0.78
EPS
-2.3627
Volume (Avg. Vol.)
170,640
Day's Range
$1.81 - $1.95
52-Week Range
$1.10 - $6.01
Dividend & Yield
N/A (N/A)